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Abstract
Background: Beclin 1 plays an essential role in autophagy; however, the regulation of Beclin 1 expression remains largely
unexplored. An earlier ChIP-on-chip study suggested Beclin 1 could be an E2F target. Previously, we also reported that 14-3-
3t regulates E2F1 stability, and is required for the expression of several E2F1 target genes. 14-3-3 proteins mediate many
cellular signaling processes, but its role in autophagy has not been investigated. We hypothesize that 14-3-3t could regulate
Beclin 1 expression through E2F1 and thus regulate autophagy.
Methods and Findings: Using the RNAi technique we demonstrate a novel role for one of 14-3-3 isoforms, 14-3-3t, in the
regulation of Beclin 1 expression and autophagy. Depletion of 14-3-3t inhibits the expression of Beclin 1 in many different
cell lines; whereas, upregulation of 14-3-3t induces Beclin 1. The regulation is physiologically relevant as an extracellular
matrix protein tenascin-C, a known 14-3-3t inducer, can induce Beclin 1 through 14-3-3t. Moreover, rapamycin-induced,
serum free-induced and amino acid starvation-induced autophagy depends on 14-3-3t. We also show the expression of
Beclin 1 depends on E2F, and E2F can transactivate the Beclin 1 promoter in a promoter reporter assay. Upregulation of
Beclin 1 by 14-3-3t requires E2F1. Depletion of E2F1, like 14-3-3t, also inhibits autophagy.
Conclusion: Taken together, this study uncovers a role for 14-3-3t in Beclin 1 and autophagy regulation probably through
regulation of E2F1.
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Introduction
Autophagy is an essential process for the lysosomal turnover of
cellular macromolecules and organelles. Deregulation of autoph-
agy has been linked to many pathological conditions, such as
cancer. A link between autophagy and cancer has been
appreciated through the observation that Beclin 1, a phylogeni-
cally conserved protein essential for autophagy, is a haplo-
insufficient tumor suppressor [1]. Beclin 1 is part of the PI(3)
kinase class III (PI(3)KC3) lipid kinase complex that plays a central
role in the induction of autophagy [2]. Beclin 1 was originally
identified as a protein binding to antiapoptotic Bcl-2 protein [3].
In addition to the activity in inhibiting apoptosis, Bcl-2 also
inhibits autophagy through its ability in binding to the Beclin 1-
PI(3)KC3 complex, an example of the interaction between two
major pathways of cell death [4].
Altered levels of Beclin 1 are seen in many pathological
conditions. Niemann-Pick C (NPC) disease is an autosomal
recessive lipid storage disorder which is often caused by loss of
function mutations in the NPC1 gene. NPC1-deficient cells showed
increased autophagy due to abnormally high levels of Beclin 1 [5].
Beclin 1 is induced at the site of traumatic brain injury and may
serve as a mechanism to dispose injured cells through autophagy
[6]. Autophagy is also induced by ischemia and further enhanced
by reperfusion in the heart. In the reperfusion phase of the
ischemia-reperfusion, Beclin 1 is induced and the elevated level of
Beclin 1 is responsible for autophagy induction since the
autophagy is significantly attenuated in Beclin 1
+/2 mice [7].
Thus, regulation of Beclin 1 appears to be an important
mechanism to control autophagy under physiological and
pathological conditions.
The tumor development in Beclin 1
+/2 mice indicates the
importance of a full level of Beclin 1 expression for its tumor
suppressor function [1]. Decreased levels of Beclin 1 are also seen
in various cancer cells [8,9]. Moreover, reduced levels of Beclin 1
protein have been correlated to poor patient outcome in many
tumor types, such as esophageal cancer [10], stage III colon cancer
[11], hepatocellular carcinoma [12] and high-grade glioma [13].
Therefore, abnormal levels of Beclin 1 expression may have
adverse consequences.
14-3-3 proteins are a family of about 30kD dimeric well-
conserved a-helical phosphoserine/threonine binding proteins.
They contain seven mammalian isoforms (b,e,c,g,s,t,f), and are
able to bind multiple protein ligands. The 14-3-3 binding proteins
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cellular processes, including mitogenesis, DNA damage check-
point, cell cycle control, and apoptosis [14]. Previously we showed
that 14-3-3t binds to ATM-phosphorylated E2F1 during DNA
damage and promotes E2F1 stability, leading to induction of E2F1
pro-apoptotic target genes such as p73, Apaf1 and caspases [15].
In this report, we investigate a role for 14-3-3t in the expression of
a putative E2F target gene involved in autophagy, Beclin 1, and
uncover its critical function in the regulation of autophagy
induction.
Results
To investigate the role of 14-3-3t in the control of gene
expression, we established U2OS cell lines stably expressing
inducible siRNA against either 14-3-3t or a control GFP sequence
under the control of tetracycline operon in pSUPERIOR.puro
vector [16]. Using these cell lines, we performed a pilot microarray
study and observed significant decrease (around 7-fold) of the
Beclin 1 transcript expression upon depletion of 14-3-3t.W e
confirmed the effect in two independent cell lines, HEK293 and
U2OS cells, which were transiently transfected by an siRNA
against 14-3-3t or a scrambled sequence. The RNA was
harvested, and the transcript levels of Beclin 1 and 14-3-3t were
measured by real-time RT-PCR (Fig. 1A). In both cell lines,
depletion of 14-3-3t led to reduced levels of Beclin 1. The change
on Beclin 1 protein level upon addition of doxycycline to induce
the expression of 14-3-3t siRNA was also confirmed by Western
blot analysis (Fig. 1B). The effect on Beclin 1 expression is truly
due to depletion of 14-3-3t since three different 14-3-3t siRNAs all
inhibited Beclin 1 expression (Fig. 1C), and Beclin 1 was restored
to its baseline level when 14-3-3t depletion was rescued with an
RNAi-resistant 14-3-3t construct (Fig. 1D). This effect was
observed in multiple cell lines including U2OS (Fig. 1A–B),
HEK293 (Fig. 1A & C), a colon cancer cell line HCT116 (Fig. 1D)
and a breast cancer cell line MCF7 (Fig. 1E), suggesting that
regulation of Beclin 1 by 14-3-3t is general rather than cell line
specific.
To investigate the regulation of Beclin 1 by 14-3-3t in a
physiological context, we made use of an extracellular matrix
protein tenascin-C, which has been reported to induce 14-3-3t in
MCF7 cells when compared with a control fibronectin matrix
protein [17]. Tenascin-C is an extracellular matrix component
which is transiently expressed in association with epithelial cell
detachment [18], proliferation, and migration. Extracellular
matrix detachment has been recognized to be able to induce
autophagy [19]. Recent studies also showed that the expression of
tenascin-C in invasion borders of early breast cancer significantly
correlates with proliferative activity, higher risk of distant
metastasis and local recurrence [20]. Expression of tenascin-C
was shown to be able to induce cell invasion through matrix
metalloproteinase in breast cancer [21] and glioma cells [22]. The
process of cell invasion can also induce autophagy [23]. We
therefore hypothesized that tenascin-C might regulate Beclin 1
through 14-3-3t. As shown in Figure 2A–B, tenascin-C induced
14-3-3t and Beclin 1 when compared with fibronectin control, and
the induction of Beclin 1 was blocked when 14-3-3t was depleted.
These results indicate that the induction of Beclin 1 by tenascin-C
is mediated through 14-3-3t. We want to point out that Beclin 1
expression was detectable both by immunoblotting and by qRT-
PCR in our MCF7 cells, despite this cell line harbors 17q21 loss of
heterozygosity for Beclin 1 [24] and was reported to express
undetectable levels of Beclin 1 [8,25,26]. It is unclear at this
moment whether the expression of the remaining Beclin 1 allele is
activated in our MCF7 cells during passages or it is simply a
matter of assay sensitivity. A role in the regulation of Beclin 1 for
14-3-3t was also evaluated by overexpression. When 14-3-3t was
overexpressed in U2OS cells, both the transcript and protein of
Beclin 1 were induced (Fig. 2C–D).
Depletion of 14-3-3t also inhibited the expression of Beclin 1
during serum starvation or rapamycin treatment in either
HEK293 cells, HCT116 cells or U2OS cells (Fig. 3A–B). Given
a pivotal role for Beclin 1 in autophagy, we then investigated
whether 14-3-3t is required for autophay. During autophagy, LC3
(microtubule-associated protein-1 light chain-3) -I is lipidated to
the LC3-II form, which integrates into the autophagosome
membrane and form a distinctly punctate distribution [27]. We
measured autophagy by detecting the appearance of LC3-II on
Western blot analysis (Fig. 3B) or by the distinctly punctate
distribution of GFP-LC3 under fluorescence microscope (Fig. 3D–
E). Indeed, 14-3-3t depletion significantly blocked autophagy
induced by either serum starvation or by rapamycin treatment
(Fig. 3B–E). When the depletion of 14-3-3t was rescued by an
RNAi-resistant construct, the expression of Beclin 1 increased and
the autophagic response to serum starvation and rapamycin was
also recovered (Fig. 3B–D). The relatively high level of autophagy
in the ‘‘rescue’’ arm of the untreated group may be a result of
overexpression of 14-3-3t (Fig. 3B–C). To further substantiate a
role for 14-3-3t in autophagy induction, we also examined the
autophagy induced by amino acid starvation by starving the cells
in Earle’s balanced salt solution (EBSS) and performed autophagy
flux analysis (Fig. 3F). We first depleted 14-3-3t in U2OS cells by
doxycycline-inducible expression of si14-3-3t (Fig. 3F, left panels)
or by infecting U2OS cells with a recombinant adenovirus
expressing si14-3-3t (Fig. 3F, right panels). EBSS treatment
induced autophagy as revealed by degradation of p62 and an
increase of LC3-II. Comparing with siGFP control, 14-3-3t
depletion decreased the extent of p62 degradation and LC3-II
formation (Fig. 3F). Upon treatment of the lysosomal inhibitor
bafilomycin A1, which prevents the autophagic degradation of p62
and LC3-II, both p62 and LC3-II levels increase. The difference
in p62 level between cells treated with bafilomycin A1 and
untreated cells represents the amount of p62 that has been
recruited into autophagic vesicles during the period of treatment.
As shown in Fig. 3F, 14-3-3t depletion inhibited the autophagic
degradation of p62. Since bafilomycin A1 inhibits the degradation
of autophagosomes, the levels of LC3-II in bafilomycin A1-treated
cells reflect the rate of autophagosome formation (autophagy flux).
By this measure, depletion of 14-3-3t also decreased the
autophagosome synthesis (Fig. 3F, left panels). Thus, combining
the GFP-LC3 punctate, p62 degradation and autophagy flux
analyses, we conclude that 14-3-3t is required for nutrient
deprivation- or rapamycin-induced autophagy.
When Weinmann and colleagues performed chromatin immu-
noprecipitation to clone the E2F-bound chromatins, Beclin 1
promoter was identified to be one of the promoters occupied by
many E2F family members [28]. This observation suggests that
Beclin 1 is an E2F target gene. Our prior study showed that 14-3-3t
regulates E2F1 stability and as such regulates many E2F1 target
genes [15]. Therefore, we investigated whether Beclin 1 is
regulated by E2F. Indeed, the expression of Beclin 1 also depends
on E2F. When E2F1, or 2 or 3 was depleted, Beclin 1 RNA
(Fig. 4A) and protein (Fig. 4B) levels were significantly reduced in
U2OS cells. Due to the fact that E2F1, 2 and 3 regulates each
other, depletion of one E2F also affected to some extent the
expression of the others. When E2F1, or 2 or 3 or 4 or 5 was
overexpressed in serum-starved T98G cells, Beclin 1 RNA
(Fig. 4C) and protein (Fig. 4D) was induced. To demonstrate that
14-3-3t Regulates Autophagy
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performed Beclin 1 promoter reporter assay in T98G cells. As
shown in Fig. 4E, both E2F1 and E2F3 trans-activated the Beclin
1 promoter activity. Taken together, these data confirmed that
Beclin 1 is an E2F target gene.
Finally, we investigated the role for E2F1 in autophagy
induction and in the regulation of Beclin 1 by 14-3-3t. Depletion
of E2F1 significantly abrogated rapamycin-induced autophagy
(Fig. 5A–C). This result is consistent with the finding that E2F1 is
required for etoposide-induced autophagy [29]. Depletion of E2F1
or deletion of E2F1 gene also affected the accumulation of Beclin 1
during overexpression of 14-3-3t (Fig. 5D–E). Taken together,
these data provide evidence for a link from 14-3-3t to autophagy
regulation through the control of E2F1-Beclin 1.
Figure 1. 14-3-3t is required for the expression of Beclin 1. (A) HEK293 and U2OS cells were transiently transfected with pSUPER-si14-3-3t [15]
or pSUPER expressing a scrambled sequence (siScr) [37]. Forty-four hr later, cells were harvested and RNA was extracted. Real-time RT-PCR analysis
was performed using primers specific for Beclin 1, 14-3-3t and GAPDH. The levels of Beclin 1 and 14-3-3t were normalized to GAPDH levels and are
expressed relative to the expression of the gene in the siScr control. The data shown represent the means 6 standard deviations of triplicate samples.
The p values are based on a paired two-tailed t test. (B) We established stable U2OS cell lines expressing an inducible siRNA against 14-3-3t or a
control GFP sequence under the control of tetracycline operon in pSUPERIOR.puro vector (OligoEngine). 14-3-3t siRNA or a GFP siRNA was induced
by doxycycline (DOX) (1 mg/ml), and cells were harvested for Western blot analysis using anti-Beclin 1, anti-14-3-3t or anti-GAPDH antibody. (C)
HEK293 cells were transiently transfected by three different pSUPER-14-3-3t siRNA constructs (20 mg) by a calcium phosphate method. The cell
lysates were harvested 48 hr later and analyzed by Western blot analysis. (D) HCT116 cells were transfected with 20 mg pSUPER-scrambled siRNA (siS)
or si14-3-3t (si14) along with a pcDNA3 empty vector or a vector expressing siRNA-resistant 14-3-3t (res) by electroporation. The cell lysates were
harvested 44 hr later and subject to Western blot analysis as indicated. (E) MCF7 cells were infected with a recombinant adenovirus expressing a
control siGFP or si14-3-3t (si14) at MOI of 100. Forty-two hr later, cells were harvested for Western blot analysis as indicated.
doi:10.1371/journal.pone.0010409.g001
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To our knowledge, this study presents the first evidence
supporting a critical role for 14-3-3 proteins in autophagy. We
also elucidate its mechanism. We demonstrate that 14-3-3t
regulates the expression of Beclin 1 through E2F1 and provide
evidence for its role in autophagy induction during nutrient
deprivation or rapamycin treatment. We also show that E2Fs can
directly regulate the Beclin 1 promoter and expression. Previously,
we showed that 14-3-3t controls E2F1 stability [15]. Thus, the role
for 14-3-3t in autophagy is likely related to its role in the
regulation of E2F1 and as a result Beclin 1 expression. Indeed,
E2F1 mediates the upregulation of Beclin 1 by 14-3-3t. Since 14-
3-3t is involved in many signaling processes, e.g. ubiquitin-
independent proteasomal degradation of p21 [30], we cannot rule
out the possibility that 14-3-3t may also be involved in other
mechanisms for autophagy induction. Importantly, we showed
that tenascin-C, an extracellular matrix protein involved in
detachment (a process which causes autophagy [19]), induces
Beclin 1 through 14-3-3t, thus placing the tenascin-C/14-3-3t/
E2F1/Beclin 1 regulation in a physiological context.
In addition to Beclin 1, E2Fs also regulate many genes involved
in autophagy. Previously, Macleod and colleagues identified
BNIP3 as an E2F-regulated gene that is involved in hypoxia-
induced autophagy [31]. Polager and coworkers also showed that
E2F1 regulates several autophagy-related genes including LC3,
autophagy-related gene-1 (ATG1) (also named UNC51-like
kinase 1, ULK1), ATG5 and damage-regulated autophagy
modulator (DRAM) [29]. The ability of E2F in inducing Beclin
1 expression (Fig. 4C–D) and the requirement of E2F1-3 for
Beclin 1 (Fig. 4A–B) in conjunction with the observation that
Beclin 1 promoter is occupied by E2F family members [28]
strongly suggest that Beclin 1 is an E2F target as well. Indeed, we
have confirmed this by showing the ability of E2F1 and E2F3 in
transactivating Beclin 1 promoter by a reporter assay (Figure 4E).
Since most E2F members occupy on the Beclin 1 promoter [28]
and induce its expression (Fig. 4C–D), Beclin 1 appears to be
regulated by multiple E2F members. Recently, Kusama at al.
amplified and cloned the putative promoter regions of 23 human
ATG genes to check their responsiveness to E2F1 in a promoter-
luciferase reporter assay. Thirteen promoters were reported to be
regulated by E2F1 in HeLa cells [32]. In addition to the known
target genes, LC3 and DRAM, other E2F1-induced promoters
are: ULK2, ATG4, ATG7, GABARAPL2, ATG9A, ATG10 and
ATG12. The promoter of GABARAPL1 was down regulated by
E2F1. Probably due to short promoter constructs for ATG1/
ULK1 (nucleotide position 2184/+6) and Beclin 1 (nucleotide
position 2207/+13) used in Kusama’s study, both were not
Figure 2. Tenascin-C upregulates Beclin 1 through 14-3-3t. (A–B) MCF7 cells were grown on Fibronectin (FN) or Tenascin C (TN) pre-treated
plates. Next day, cells were infected with Adsi14-3-3t or control AdsiScr virus at MOI 100 for 48 hrs. Cells were then harvested for Western blot (A,
upper panels), semiquantitative RT-PCR (A, lower panels), and real-time RT-qPCR analyses (B). No RNA lane represents a control RT-PCR reaction
without input RNA. Quantitative PCR was performed in triplicate. The levels of Beclin 1 were normalized to GAPDH levels and are expressed relative to
the expression of the gene in the siScr FN control. The data shown represent the means 6 standard deviations of three independent samples. The p
values are based on a paired two-tailed t test. (C–D) U2OS cells were infected by Ad14-3-3t (Ad14) or an empty vector AdCMV (CMV) at MOI 300 for 2
days. Protein and RNA were harvested for Western blot analysis (C) or real-time RT-qPCR (D). Quantitative PCR was performed in triplicate. The levels
of Beclin 1 were normalized to GAPDH levels and expressed relative to the expression of the gene in the AdCMV control. The data shown represent
the means 6 standard deviations of three independent samples. The p values are based on a paired two-tailed t test.
doi:10.1371/journal.pone.0010409.g002
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expression in nutrient limited conditions. HEK293 or HCT116 cells were transfected with 20 mg pSUPER-si14-3-3t or pSUPER-siScr. 24 hours later, cells
were either left in nutrient-full medium (w/serum) or serum free medium (medium without supplement of serum) for 48 hours. Western blot analysis
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our study comprises 949 bp (nucleotide position 2856/+93). This
suggests that the E2F-responsive sequences in the Beclin 1
promoter might be located within the 2856/+93 region, but
outside of the 2207/+13 region. However, we cannot rule out
the possibility that other elements of the promoter more upstream
to 2856 might be important for optimal expression of Beclin 1. A
putative Beclin 1 promoter DNA fragment has been shown to
have a high-affinity E2F in vivo binding, but interestingly does
not contain a consensus E2F site [28]. Nevertheless, it does
contain extremely GC-rich sequences, which is a hallmark of
many E2F-regulated promoters. Recently, it was also reported
that Beclin 1 promoter could be activated by NFkB [33]. A
detailed analysis of the Beclin 1 promoter is warranted in the
future.
Our results identify 14-3-3t as an important regulator for Beclin
1 and autophagy. With the involvement of 14-3-3 in many
important biological signaling processes, this regulation provides a
potential link between these processes and autophagy. For
example, tenascin-C signaling is involved in extracellular matrix
detachment which can induce autophagy [19]. Through the
induction of 14-3-3t, tenascin-C can in turn up-regulates Beclin 1
expression (Fig. 2). This could contribute to the autophagy
induced by cell invasion. It is desirable to further test the
regulation in other physio/pathological contexts, for example, the
induction of Beclin 1 and autophagy during reperfusion phase
after cardiac ischemia. While our data show a role for 14-3-3t in
the expression of Beclin 1, and autophagy induction during
nutrient depletion or rapamycin treatment, high expression of 14-
3-3t or Beclin1 alone may not induce autophagy. However, high
levels of 14-3-3t or Beclin 1 in certain physio/pathological
conditions might prime cells for autophagy when the cells
receive the autophagy stimuli. This possibility deserves future
investigation.
Materials and Methods
Cell culture and transfection
HEK293, breast cancer cell line MCF7, cervical cancer cell line
HeLa, and glioblastoma cell line T98G were grown in Dulbecco’s
modified Eagle’s medium (DMEM) supplemented with 10% fetal
bovine serum (FBS), penicillin (50 IU/ml), and streptomycin
(50 mg/ml) in a humidified incubator with 5% CO2 at 37uC.
Colon carcinoma cell line HCT116 and human osteosarcoma cell
line U2OS were maintained in McCoy’s 5A supplemented with
10% fetal bovine serum (FBS), penicillin (50 IU/ml), and
streptomycin (50 mg/ml). MCF7 cell line is a gift from J. Michael
Ruppert. All other cell lines were purchased from ATCC. Cells
were transfected by the calcium phosphate method, Lipofectamine
2000 (Invitrogen) according to manufacturer’s protocol, or the
Gene Pulser Xcell electroporation system (Bio-Rad). The Gene
Pulser Xcell electroporation conditions for HCT116 cells are:
Voltage 155 V, Capacitance 1000 mF, Resistance /V,2 0 mg
DNA in 200 ml tranfection medium (McCoy’s 5A without
supplement) within 2 mm Bio-Rad electroporation cuvettes.
Bafilomycin A1 was purchased from Fisher Scientific (Pittsburgh,
PA). E2F1
+/+ and E2F1
2/2 primary mouse embryonic fibroblasts
(MEFs) (passage 3) were prepared from 13.5-day-old embryos and
grown in DMEM supplemented with 10% FBS as described
[34,35]. We followed the protocol described in Jackson Laboratory
Genotyping Protocol# 002785, http://jaxmice.jax.org/proto-
colsdb for genotyping of the E2F1-knockout MEFs. Earle’s
balanced salt solution (EBSS) was purchased from Gibco-
Invitrogen Co.
Recombinant Plasmids and adenoviruses
The construction of pCMV-SPORT6-14-3-3t, pSUPER-si14-
3-3t, pSUPER-siE2F1, pSUPER-siE2F2, pSUPER-siE2F3 has
been described [15]. The 19-nt target sequences for si14-3-3t #1:
59-GGACTATCGGGAGAAAGTG-39; si14-3-3t#2: 59- CGAG-
GAGCGCAACCTGCTC-39; si14-3-3t#3: 59-GAACGTGGTC-
GGGGGCCGC-39. To construct an siRNA-resistant expression
vector and rescue the depletion by si14-3-3t #1, the pCMV-
SPORT6-14-3-3t was used to generate a silent mutation by
changing four nucleotides (59-GCTGATTAAGGACTACAGA-
GAAAAAGTGGAGTCCGAG-39) using the QuickChange site-
directed mutagenesis kit (Stratagene). The mutation was verified
by sequencing. To construct Adsi14-3-3t and AdsiGFP, the NotI/
SalI fragments of pSUPER constructs containing H1 RNA gene
promoter and si14-3-3t or siGFP were cloned to pShuttle followed
by recombination with an AdEasy vector. Ad14-3-3t was
constructed by moving the siRNA-resistant 14-3-3t cDNA from
pCMV-SPORT6-14-3-3t by XhoI/NotI to pShuttle-CMV fol-
lowed by recombination with an AdEasy vector. All viruses were
purified by a double CsCl banding procedure in a Beckman
ultracentrifuge.
Real-time RT-PCR
RNA was extracted using TRIzol reagent (Invitrogen). Equal
amounts (2 mg) of RNA were used for first strand cDNA synthesis
with reverse transcriptase. An equal portion of the mixture was
used for PCR reactions to detect the expression of Beclin 1 and 14-
3-3t with the following primer pairs: Beclin 1, 59-CTTACCA-
CAGCCCAGGCGAAAC-39, and 59-GCCAGAGCATGGAG-
CAGCAA-39; 14-3-3t,5 9-TCCTGCACTGTCTGATGTCC-39,
and 59-GGACTATCGGGAGAAAGTGG-39 with annealing
temperature set at 58uC (Beclin 1) or 62uC (14-3-3t) for 25 cycles.
For quantitative PCR, each sample was performed in triplicate on
an MX3005P thermal cycler (Stratagene) using the SYBR green
dye method to track the progress of the reactions with ROX dye
added as reference. The qPCR program for Beclin1 is: 95uC
30 sec, 58uC 1 min and 72uC 1 min; the qPCR program for 14-3-
3t is: 95uC 30 sec, 62uC 1 min and 72uC 1 min. GAPDH was run
was performed using antibodies as indicated. (B–E) U2OS cells were transiently transfected with 5 mg GFP-LC3 by Lipofectamine. 24 hr later, the cells
were infected with AdsiGFP or Adsi14-3-3t (MOI 100) along with an empty vector AdCMV or a recombinant adenovirus expressing siRNA-resistant 14-
3-3t (res) (MOI 30). Next day, the cells were treated with 100 nM rapamycin for 24 hours or left in serum-free medium for 48 hours. (B) Some cells
were harvested and subject to Western blot analysis as indicated. GFP-LC3 was probed with an anti-GFP antibody. (C–E) Cells were scored for GFP–
LC3 autophagosomes-positivity as described in Materials and Methods. The graphs represent data derived from three independent experiments with
means 6 standard deviations. The p values are based on a paired two-tailed t test. (D): High magnification (10006) images of representative cells. (E):
Lower magnification (2006) images of representative fields. (F) Autophagy flux analysis. Left panel: The doxycline-inducible siRNA stable U2OS cell
lines as described in Fig. 1B were first treated with doxycycline (1 mg/ml) for 7 days to deplete14-3-3t. The cells were then washed with PBS for three
times and then starved in Earle’s balanced salt solution (EBSS) or EBSS with bafilomycin A1 (BafA) (0.1 mM) in 37uC for 2 hr before harvesting for
Western blot analysis. Right panel: U2OS cells were infected with AdsiGFP or Adsi14-3-3t at MOI 200. Three days later, the cells were washed with PBS
and starved with EBSS or with EBSS + BafA as above for 3 hr. The cells were then harvested for Western blot analysis as indicated.
doi:10.1371/journal.pone.0010409.g003
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reported [36]. Results were analyzed with MxPro 4.0 quantitative
PCR software (Stratagene).
GFP-LC3 punctates quantification
HeLa cells were transiently transfected with GFP-LC3 and
siRNA constructs. 24 hr later, cells were then treated with 100 nM
rapamycin for 24 hr. Cells were then fixed in 1% paraformalde-
hyde, and nuclei were stained with Hoechst 33258. Cells were
examined by fluorescence microscopy. To quantify GFP–LC3
autophagosomes-positive cells, multiple random fields representing
more than 500 GFP-positive cells were counted. Cells with five or
more GFP-LC3 vacuoles (puncta) were considered positive for
autophagy.
Figure 4. E2Fs regulate Beclin 1. (A–B) In addition to the doxycycline-inducible si14-3-3t stable cell line as described in figure 1B, we also
established stable U2OS cell lines expressing an inducible siRNA against E2F1, E2F2 or E2F3 [36] under the control of tetracycline operon in the
pSUPERIOR.puro vector. 14-3-3t siRNA, E2F siRNA or GFP siRNA was induced by doxycycline treatment (1 mg/ml) and cells were harvested for RNA
extraction/RT-PCR assays (A), and for Western blot analysis (B). No RNA lane represents a control RT-PCR reaction without input RNA. (C–D) T98G cells
were serum-starved for 48 hours and then infected by AdE2F1, AdE2F2, AdE2F3, AdE2F4 or AdE2F5 at MOI 200 for 24 hours. Cell lysates were then
analyzed by RT-PCR assays (C) or Western blot analysis (D). (E) The activities of E2F1 and E2F3 toward the Beclin 1 promoter were tested in T98G cells
using a human Beclin 1 promoter-Luciferase (BECN1p-Luc) reporter construct as described in the Materials and Methods. (*) P,0.05 (paired two-tailed
t test) compared with AdCMV control infection in BECN1p-Luc transfected cells. Right panels: a portion of the cellular lysates was immunoblotted
with antibody for E2F1, E2F3 or b-actin.
doi:10.1371/journal.pone.0010409.g004
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The transfected cells were harvested in SDS lysis buffer (1%
SDS, 60 mM Tris PH 6.8) and the lysates were boiled for 5 min
followed by a brief sonication to homogenize the lysates. Equal
amounts (100 mg) of protein lysates were fractionated by SDS-
PAGE and electrotransferred to an Immobilon-P membrane
(Millipore). Equal protein loading was confirmed with Ponceau-S
staining. The specific signals were detected with appropriate
antibodies. The antibodies specific to 14-3-3t (C-17), BECN1 (E8),
E2F1 (KH95), E2F2 (C20), E2F3 (C-18), E2F4 (WUF11), E2F5
Figure 5. A role for E2F1 in autophagy and the regulation of Beclin 1 by 14-3-3t. (A–C) HeLa cells were transiently transfected with 3 mg
GFP-LC3 and 20 mg pSUPER-siE2F1 or pSUPER-siScr using Lipofectamine 2000. 24 hr later, the cells treated with 100 nM rapamycin for 24 hr to induce
autophagy. (A) Cells were fixed in 1% paraformaldehyde, and nuclei were stained with Hoechst 33258. Images were taken with 2006magnification in
a Zeiss Axioplan 2 digital fluorescence microscope. (B) More than 500 GFP-positive cells per sample were scored for GFP-LC3 puncta. The data are
derived from three independent experiments. The data shown represent the means 6 standard deviations. The p values are based on a paired two-
tailed t test. (C) Some cells were harvested and the cellular lysates were subject to Western blot analysis as indicated. (D) The E2F1 siRNA or GFP siRNA
in the U2OS cell lines as described in Fig. 4A–B was induced by doxycycline (1 mg/ml) for 3 days, and then the cells were infected with AdCMV or 14-3-
3t at MOI 300. 48 hr later, cells were harvested for Western blot analysis. (E) Primary E2F1
+/+ or E2F1
2/2 mouse embryonic fibroblasts (MEFs) were
infected with AdCMV or 14-3-3t at MOI 1000. 48 hr later, cells were harvested for Western blot analysis (Right panel). Left panel: Genotyping of the
MEFs. The 172-bp and 227-bp products were amplified from the wild type and mutant alleles respectively. Mock represents no template input
control.
doi:10.1371/journal.pone.0010409.g005
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from Santa Cruz Biotechnology (Santa Cruz, CA). The monoclo-
nal antibody for 14-3-3t (3B9) and b-actin antibody (A2066) were
purchased from Sigma (St Louis, MO). LC3 antibody (NB100-
2220) was purchased from Novus Biologicals (Littleton, CO), and
mouse monoclonal p62 antibody (clone 2C11, cat. number:
H00008878-M01) was obtained from Abnova (Taipei, Taiwan).
On average, the western blot analysis was performed two to three
times to ensure the reproducibility of the data.
Luciferase assay
Beclin 1-promoter-Luciferase reporter construct was obtained
from Switchgear Genomics (product ID: S119414). This pGL-
based vector construct contains a 949-bp human Beclin 1
promoter. An empty pGL3-Basic vector was used as a control.
T98G cells were transfected using Lipofectamine 2000 reagent
with promoter plasmid (5 mg) and pCMV-b-galactosidase plasmid
(5 mg) and grown in DMEM with 10% FBS. Sixteen hr later, the
media were replaced with serum-free DMEM and then cells were
infected with a control AdCMV empty vector virus or AdE2F1 or
AdE2F3 at MOI of 200. Cells were grown in serum-free media for
additional 36 hr. Cells were harvested in PBS; an aliquot was lysed
in SDS lysis buffer for Western blotting, while the rest of the
sample was lysed in reporter lysis buffer (Promega). Luciferase
activity and b-galactosidase activity were measured according to
manufacturer instruction. Luciferase activity was normalized
against b-galactosidase activity. All assays were performed in
triplicate.
Statistical analysis
The levels of Beclin 1 and 14-3-3t were measured by
quantitative RT-PCR and then normalized to GAPDH levels.
The experiment was run in triplicate for each sample. The
differences of the levels between samples were compared using
paired two-tailed t test. P values less than 0.05 were considered
statistically significant. GFP-LC3 punctate-positive cells were
scored under fluorescence microscope. Each experiment was run
in triplicate, and more than 500 GFP-positive cells were scored per
slide. The differences of the percentages between samples were
compared by paired two-tailed t test. Each sample in the Beclin 1
promoter luciferase reporter assay was also run in triplicate and
the differences between samples were compared using paired two-
tailed t test.
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